No results for ‘’
Fredun Pharmaceuticals Ltd
₹1412.20
(3.35%)
Sat, 12 Sept 2026, 07:05 am
Health Technology
Pharmaceuticals: Major
24.5KFredun Pharmaceuticals Share Price Live Chart
1 Day
(3.35%)
No Result Found
Summary
Market Cap (in Cr)
1375.72
Net Profit (in Cr)
20.81
P/B
2.25
Sector P/E
33.76
P/E
15.99
EV/EBITDA
8.70
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
13.96
ROCE
15.97
Debt/Equity
1.18
EPS (TTM)
59.17
Dividend Yield
0.03
Book Value
513.57
Interest Cover
2.23
Analysis
all
- Fredun Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Fredun Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Fredun Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 3.3x debt.
- Fredun Pharmaceuticals's cash and other short term assets cover its long term commitments.
- Fredun Pharmaceuticals is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Fredun Pharmaceuticals's dividends as it is not paying a notable one for India.
- Fredun Pharmaceuticals is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Fredun Pharmaceuticals's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.75%).
- Fredun Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.09%).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 44.17 | 43.06 | 48.93 | 48.93 | 48.93 |
| FII | 1.06 | 0.46 | 0.01 | 0 | 0 |
| DII | 2.83 | 3.48 | 1.60 | 1.59 | 1.59 |
| Public | 51.94 | 53.00 | 49.45 | 49.48 | 49.48 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2566.33 | 1956.43 | 1702.97 | 1346.53 | 1093.07 | 736.63 | 126.73 |
| Fibonacci | 1956.43 | 1723.45 | 1579.52 | 1346.53 | 1113.55 | 969.62 | 736.63 |
| Camarilla | 1617.22 | 1561.32 | 1505.41 | 1346.53 | 1393.59 | 1337.68 | 1281.78 |
Pivots Level: Classic
R3
+1219.80
2566.33
R2
+609.90
1956.43
R1
+356.43
1702.97
S1
-253.47
1093.07
S2
-609.90
736.63
S3
-1219.80
126.73
Moving Average
Period
Value
10-EMA
1439.65
20-EMA
1412.12
30-EMA
1359.01
50-EMA
1253.36
100-EMA
1067.25
200-EMA
862.30
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 25 May 2026 | board-meetings | Accounts, Quarterly Results, Final Dividend, Bonus Issue | |
| 09 Feb 2026 | board-meetings | Quarterly Results | |
| 19 Jan 2026 | egm | ||
| 08 Nov 2025 | board-meetings | Quarterly Results | |
| 27 Sept 2025 | egm | ||
| 15 Sept 2025 | agm | ||
| 23 Aug 2025 | dividend | Final Dividend - Rs. - 0.7 | 23 Sept 2025 |
| 31 May 2025 | dividend | ₹0.70 Dividend /Share | 23 Sept 2025 |
| 18 Sept 2024 | agm | ||
| 23 Aug 2024 | dividend | Final Dividend - Rs. - 0.7 | 23 Sept 2024 |
Peer Comparison
Fredun Pharmaceuticals Ltd
Cipla Ltd
Divis Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd About
Fredun Pharmaceuticals is dedicated to improving lives of people. Company’s aim is not only profitability but is effective efficiency. With years of experience in manufacturing various pharmaceutical formulations Fredun Pharmaceuticals Ltd has built a good reputation as a reliable and ethical Company having buyers which not only include leading Pharma Companies of India but also across Africa, South East Asia and CIS countries and Latin America.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1987
Headquarters
CEO
Daulat N Medhora
Employees
Contact
Website
http://www.fredungroup.com
business@fredungroup.com
Phone
91-22-40318111
Location
26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, Mumbai, Maharashtra, 400031
Fredun Pharmaceuticals Ltd Company History
| Year | History |
|---|---|
| 1987 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| ASHOK JHINGAN | bulk | Sell | 24000 | 443.07 | 14 Sept 2021 |
| ANAND JHINGAN | bulk | Sell | 24758 | 422.48 | 14 Sept 2021 |
| ZAHEER . | bulk | Sell | 112025 | 183.28 | 01 Jul 2020 |
| KAMAL KUMAR JALAN SEC. PVT. LTD | bulk | Buy | 33872 | 184.83 | 01 Jul 2020 |
| KAMAL KUMAR JALAN SEC. PVT. LTD | bulk | Sell | 33697 | 187.3 | 01 Jul 2020 |
| SURINDER GURMUKH DHAUL | bulk | Buy | 24881 | 183.48 | 01 Jul 2020 |
| SURINDER GURMUKH DHAUL | bulk | Sell | 24881 | 186.19 | 01 Jul 2020 |
| ZAHEER . | bulk | Buy | 112025 | 186.01 | 01 Jul 2020 |
| MADHUBALA PARESH TRIVEDI | bulk | Sell | 15400 | 142.7 | 15 Jan 2018 |
Frequently Asked Questions
1.What is the stock price of Fredun Pharmaceuticals Ltd?
As of 12/09/2026 at 12:35 PM, Fredun Pharmaceuticals Ltd shares are trading at ₹1412.20.
2.What is the market cap. of Fredun Pharmaceuticals Ltd?
As of 12/09/2026, the market capitalization of Fredun Pharmaceuticals Ltd is ₹2,426.38 crore.
3.When was Fredun Pharmaceuticals Ltd founded?
Fredun Pharmaceuticals Ltd was founded in 1987.
4.What are the P/E and P/B ratios of Fredun Pharmaceuticals Ltd?
As of 12/09/2026, Fredun Pharmaceuticals Ltd has a P/E ratio of 51.31 and a P/B ratio of 2.25.
5.How can I buy shares of Fredun Pharmaceuticals Ltd?
You can buy shares of Fredun Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Fredun Pharmaceuticals Ltd?
As of March,2026, promoters hold 44.17% in Fredun Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 1.06%, 2.83% and 51.94%, respectively.
7.Does Fredun Pharmaceuticals Ltd pay dividends?
Yes, Fredun Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.7 per share.
8.What is the dividend yield of Fredun Pharmaceuticals Ltd?
As of 12 September, 2026, the dividend yield of Fredun Pharmaceuticals Ltd stands at 0.02%.
9.What are the latest financial results of Fredun Pharmaceuticals Ltd?
For January,2024, Fredun Pharmaceuticals Ltd reported revenue of ₹454.00 crore and a net profit of ₹19.74 crore.
10.Who is the CEO of Fredun Pharmaceuticals Ltd?
The CEO of Fredun Pharmaceuticals Ltd is Daulat N Medhora.